| Phase 01 trial |
|
Phase 0
|
NCT04801264 |
Sep 2020 → Sep 2022 |
adenoid cystic carcinoma |
Peking Union Medical College Hospital |
Unknown
|
No outcome recorded
|
| Phase 1/21 trial |
|
Phase 1/2
|
NCT04614363 |
Oct 2020 → Feb 2022 |
prostate cancer |
The Methodist Hospital Research Institute |
Completed
|
No outcome recorded
|
| Phase 27 trials · 1 met primary |
|
Phase 2
|
NCT06560905 |
Mar → Dec 2025 overdue |
melanoma |
Royal Marsden NHS Foundation Trust |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05214820 |
Jan 2022 → Dec 2026 expected |
digestive system cancer |
Centre de recherche du Centre hospitalier universitaire de Sherbrooke |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT06484361 |
Sep 2020 → Sep 2025 |
prostate cancer |
IRCCS San Raffaele |
Unknown
|
No outcome recorded
|
|
Phase 2
|
NCT05806853 |
Jun 2020 → Oct 2022 |
prostate cancer |
IRCCS San Raffaele |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT03689582 |
Nov 2018 → Feb 2020 |
prostate cancer |
University of Michigan Rogel Cancer Center |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT03396874 |
Feb 2018 → Aug 2022 |
metastatic prostate carcinoma, prostate adenocarcinoma |
University of Michigan |
Completed
|
Met primary
|
|
Phase 2
|
NCT02282137 |
May 2015 → Dec 2022 |
prostate cancer |
Ebrahim Delpassand |
Unknown
|
No outcome recorded
|
| Phase not applicable5 trials |
| — |
NCT06355843 |
Apr 2022 → Sep 2023 |
prostate cancer |
The First Affiliated Hospital of Anhui Medical University |
Suspended
|
No outcome recorded
|
| — |
NCT05170555 |
Dec 2021 → Oct 2022 |
renal cell carcinoma |
Peking Union Medical College Hospital |
Unknown
|
No outcome recorded
|
| — |
NCT05006326 |
Aug 2021 → Dec 2023 |
cancer |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
Unknown
|
No outcome recorded
|
| — |
NCT03453528 |
Jul 2017 → Dec 2024 |
castration-resistant prostate carcinoma |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
Completed
|
No outcome recorded
|
| — |
NCT02920229 |
Nov 2015 → Oct 2020 |
prostate cancer |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
Completed
|
No outcome recorded
|